Increased prevalence of subclinical myocardial dysfunction in PsA with higher disease activityJuly 24, 2023Psoriatic Arthritis
Anti-TNF-α therapy reduces incidence of nailfold capillaroscopic abnormalities in PsAJuly 24, 2023Psoriatic Arthritis
Improvement in patient-reported outcomes comparable with ustekinumab and TNFi in PsAJuly 24, 2023Psoriatic Arthritis
Apremilast offers a safe long-term oral treatment option for psoriatic arthritisJuly 24, 2023Psoriatic Arthritis
Predictors of treatment response in PsA patients initiating a first TNFiJuly 24, 2023Psoriatic Arthritis
Beta-defensin-2 may serve as a predictive biomarker for clinical response to secukinumab in PsAJuly 24, 2023Psoriatic Arthritis
Rheumatology NewsHumira biosimilars: Five things to knowJuly 19, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsRemote teams offer chance to improve difficult-to-treat PsAJuly 18, 2023Psoriatic Arthritis
Rheumatology NewsKeep depression, anxiety screening top of mind in patients with psoriatic diseaseJuly 18, 2023Psoriatic Arthritis
Rheumatology NewsOral IL-23 receptor antagonist for psoriasis promising: Phase 2b studyJuly 11, 2023Psoriatic Arthritis
Rheumatology NewsFor psoriasis, review finds several biosimilars as safe and effective as biologicsJune 30, 2023Psoriatic ArthritisBusiness of Medicine
Rheumatology NewsDoes colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?June 30, 2023GoutRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
